A carregar...
Small molecule tyrosine kinase inhibitors in pancreatic cancer
Pancreatic cancer has proven to be chemo-resistant, with gemcitabine being the only cytotoxic agent approved for advanced pancreatic cancer since 1996. Tyrosine kinase inhibitors represent a newer generation of chemotherapeutic agents targeting specific tumor pathways associated with carcinogenesis...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2727890/ https://ncbi.nlm.nih.gov/pubmed/19707451 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|